These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Integrated molecular characterization of IDH-mutant glioblastomas. Korshunov A; Casalini B; Chavez L; Hielscher T; Sill M; Ryzhova M; Sharma T; Schrimpf D; Stichel D; Capper D; Reuss DE; Sturm D; Absalyamova O; Golanov A; Lambo S; Bewerunge-Hudler M; Lichter P; Herold-Mende C; Wick W; Pfister SM; Kool M; Jones DTW; von Deimling A; Sahm F Neuropathol Appl Neurobiol; 2019 Feb; 45(2):108-118. PubMed ID: 30326163 [TBL] [Abstract][Full Text] [Related]
10. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status. Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668 [TBL] [Abstract][Full Text] [Related]
11. IDH-mutant diffuse gliomas: tips and tricks in the era of genomic tumor classification. Ammendola S; Broggi G; Barresi V Histol Histopathol; 2023 Jul; 38(7):739-753. PubMed ID: 36651583 [TBL] [Abstract][Full Text] [Related]
12. MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas. Wu CC; Jain R; Neto L; Patel S; Poisson LM; Serrano J; Ng V; Patel SH; Placantonakis DG; Zagzag D; Golfinos J; Chi AS; Snuderl M Neuroradiology; 2019 Sep; 61(9):1023-1031. PubMed ID: 31134296 [TBL] [Abstract][Full Text] [Related]
13. CDKN2A mutations have equivalent prognostic significance to homozygous deletion in IDH-mutant astrocytoma. Yokoda RT; Cobb WS; Yong RL; Crary JF; Viapiano MS; Walker JM; Umphlett M; Tsankova NM; Richardson TE J Neuropathol Exp Neurol; 2023 Sep; 82(10):845-852. PubMed ID: 37550258 [TBL] [Abstract][Full Text] [Related]
14. DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. Christensen BC; Smith AA; Zheng S; Koestler DC; Houseman EA; Marsit CJ; Wiemels JL; Nelson HH; Karagas MR; Wrensch MR; Kelsey KT; Wiencke JK J Natl Cancer Inst; 2011 Jan; 103(2):143-53. PubMed ID: 21163902 [TBL] [Abstract][Full Text] [Related]
15. Novel, improved grading system(s) for IDH-mutant astrocytic gliomas. Shirahata M; Ono T; Stichel D; Schrimpf D; Reuss DE; Sahm F; Koelsche C; Wefers A; Reinhardt A; Huang K; Sievers P; Shimizu H; Nanjo H; Kobayashi Y; Miyake Y; Suzuki T; Adachi JI; Mishima K; Sasaki A; Nishikawa R; Bewerunge-Hudler M; Ryzhova M; Absalyamova O; Golanov A; Sinn P; Platten M; Jungk C; Winkler F; Wick A; Hänggi D; Unterberg A; Pfister SM; Jones DTW; van den Bent M; Hegi M; French P; Baumert BG; Stupp R; Gorlia T; Weller M; Capper D; Korshunov A; Herold-Mende C; Wick W; Louis DN; von Deimling A Acta Neuropathol; 2018 Jul; 136(1):153-166. PubMed ID: 29687258 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas. Galbraith K; Garcia M; Wei S; Chen A; Schroff C; Serrano J; Pacione D; Placantonakis DG; William CM; Faustin A; Zagzag D; Barbaro M; Eibl MDPGP; Shirahata M; Reuss D; Tran QT; Alom Z; von Deimling A; Orr BA; Sulman EP; Golfinos JG; Orringer DA; Jain R; Lieberman E; Feng Y; Snuderl M Neuro Oncol; 2024 Jun; 26(6):1042-1051. PubMed ID: 38243818 [TBL] [Abstract][Full Text] [Related]
17. Suppression of antitumor immune signatures and upregulation of VEGFA as IDH-mutant gliomas progress to higher grade. Grewal EP; Richardson LGK; Sun J; Ramapriyan R; Martinez-Lage M; Miller JJ; Cahill DP; Choi BD; Curry WT Neurosurg Focus; 2024 Feb; 56(2):E2. PubMed ID: 38301244 [TBL] [Abstract][Full Text] [Related]
18. Diffuse Astrocytoma, IDH-Wildtype: A Dissolving Diagnosis. Hasselblatt M; Jaber M; Reuss D; Grauer O; Bibo A; Terwey S; Schick U; Ebel H; Niederstadt T; Stummer W; von Deimling A; Paulus W J Neuropathol Exp Neurol; 2018 Jun; 77(6):422-425. PubMed ID: 29444314 [TBL] [Abstract][Full Text] [Related]
19. Isocitrate Dehydrogenase Mutations Are Associated with Different Expression and DNA Methylation Patterns of OLIG2 in Adult Gliomas. Mo H; Magaki S; Deisch JK; Raghavan R J Neuropathol Exp Neurol; 2022 Aug; 81(9):707-716. PubMed ID: 35856894 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma. Ghisai SA; van Hijfte L; Vallentgoed WR; Tesileanu CMS; de Heer I; Kros JM; Sanson M; Gorlia T; Wick W; Vogelbaum MA; Brandes AA; Franceschi E; Clement PM; Nowak AK; Golfinopoulos V; van den Bent MJ; French PJ; Hoogstrate Y Acta Neuropathol; 2024 Oct; 148(1):50. PubMed ID: 39382765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]